Back
Apellis Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
APLS
Apellis Pharmaceuticals
Last Price:
$20.06
Seasonality Move:
-18.71%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight buying pressure.
Apellis Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.06 | Buy |
| 20-day SMA: | 18.37 | Buy |
| 50-day SMA: | 18.23 | Buy |
| 200-day SMA: | 25.19 | Sell |
| 8-day EMA: | 19.2 | Buy |
| 20-day EMA: | 18.72 | Buy |
| 50-day EMA: | 18.92 | Buy |
| 200-day EMA: | 25.65 | Sell |
Apellis Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 59.4 | Buy |
| Chaikin Money Flow: | 346971 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.69 - 19.33) | Buy |
| Bollinger Bands (100): | (17.12 - 23.54) | Sell |
Apellis Pharmaceuticals Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Apellis Pharmaceuticals Stock
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 19.75 while APLS 8-day simple moving average is 19.06, which is a Buy signal.
-
The stock price of APLS is 19.75 while Apellis Pharmaceuticals 20-day SMA is 18.37, which makes it a Buy.
-
Apellis Pharmaceuticals 50-day simple moving average is 18.23 while APLS share price is 19.75, making it a Buy technically.
-
APLS stock price is 19.75 and Apellis Pharmaceuticals 200-day simple moving average is 25.19, creating a Sell signal.
APLS Technical Analysis vs Fundamental Analysis
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy or a Sell?
-
Apellis Pharmaceuticals stock is rated a SellThe current Apellis Pharmaceuticals [APLS] share price is $19.75. The Score for APLS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Apellis Pharmaceuticals Stock Info
Market Cap:
2.5B
Price in USD:
19.75
Share Volume:
1.1M
Apellis Pharmaceuticals 52-Week Range
52-Week High:
41.94
52-Week Low:
16.10
Sell
34
Apellis Pharmaceuticals (APLS)
is a Sell
Apellis Pharmaceuticals Share Price Forecast
-
What is the Apellis Pharmaceuticals stock price today?The Apellis Pharmaceuticals stock price is 19.75 USD today.
-
Will APLS stock go up or go down?Apellis Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Apellis Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Apellis Pharmaceuticals is overvalued.
Is Apellis Pharmaceuticals Stock a Buy?
-
Apellis Pharmaceuticals share price is 19.75 while APLS 8-day exponential moving average is 19.20, which is a Buy signal.
-
The stock price of APLS is 19.75 while Apellis Pharmaceuticals 20-day EMA is 18.72, which makes it a Buy.
-
Apellis Pharmaceuticals 50-day exponential moving average is 18.92 while APLS share price is 19.75, making it a Buy technically.
-
APLS stock price is 19.75 and Apellis Pharmaceuticals 200-day simple moving average is 25.65, creating a Sell signal.
Fundamental Analysis of Apellis Pharmaceuticals
Is Apellis Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.18 per share, an increase this year of $0.28 per share, and an increase next year of $0.56 per share.
Technical Analysis of Apellis Pharmaceuticals
Should I short Apellis Pharmaceuticals stock?
-
APLS Moving Average Covergence Divergence (MACD) indicator is 0.32, suggesting Apellis Pharmaceuticals is a Buy
-
Apellis Pharmaceuticals Relative Strength Index (RSI) is 59.4, which suggest Apellis Pharmaceuticals is overbought
-
The Bollinger Bands (25) for Apellis Pharmaceuticals is (17.69 - 19.33), which suggest Apellis Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Apellis Pharmaceuticals is (17.12 - 23.54), which suggest Apellis Pharmaceuticals is a Sell
* Apellis Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.